2010-09-03
Helicobacter pylori-associated malignancies: Genetics, Epidemiology and Gastric Cancer Risk
Publication
Publication
Helicobacter pylori geassocieerde maligniteiten: Genetica, epidemiologie en maagkanker risico
Helicobacter pylori infection affects at least 50% of the world population. The chronic inflammation caused by H. pylori can progress to pre-malignant gastric lesions, gastric adenocarcinoma and gastric MALT lymphoma. The widespread high prevalence of H. pylori explains that gastric cancer remains the fourth most common cancer and second leading cause of cancer related death worldwide. For these reasons, data on epidemiology and screening and surveillance options for gastric cancer in patients with H. pylori-associated malignancies may lead to a reduction in gastric cancer mortality. In the first chapter the aims and outline of this these are described. In the second chapter of this thesis we describe a pilot study on the association between H. pylori susceptibility and genetic factors.
| Additional Metadata | |
|---|---|
| , , , , | |
| AstraZeneca BV, Tramedico BV, Olympus Nederland B.V., Solvay Pharma BV, Roche Nederland B.V., Ferring Pharmaceuticals, Erasmus MC Rotterdam | |
| E.J. Kuipers (Ernst) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/20708 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Capelle, L. (2010, September 3). Helicobacter pylori-associated malignancies: Genetics, Epidemiology and Gastric Cancer Risk. Retrieved from http://hdl.handle.net/1765/20708 |
|
| Additional Files | |
|---|---|
| Stellingen_Samenvat_L.G. Capelle.pdf , 72kb | |
| 3145_Capelle, Lisette Geraldine.jpg Cover Image , 12kb | |
